Community-Acquired Pneumonia in Pregnancy

被引:34
作者
Sheffield, Jeanne S. [1 ]
Cunningham, F. Gary [1 ]
机构
[1] Univ Texas SW Med Ctr Dallas, Dept Obstet & Gynecol, Dallas, TX 75390 USA
关键词
VARICELLA-ZOSTER-VIRUS; INFECTIOUS-DISEASES; RISK-FACTORS; MANAGEMENT; GUIDELINES; ACYCLOVIR;
D O I
10.1097/AOG.0b013e3181b8e76d
中图分类号
R71 [妇产科学];
学科分类号
100211 ;
摘要
Community-acquired pneumonia is a common disease worldwide, with considerable morbidity and mortality. In the United States, pneumonia complicates 0.5 to 1.5 per 1,000 pregnancies. Physiologic adaptations in the respiratory and immunologic systems may increase susceptibility to pulmonary infections as well as alter their clinical course. Bacterial, viral and fungal pathogens all cause pneumonia in pregnancy, although the causative agent is identified in only 40-60% of cases. The most common single pathogen is Streptococcus pneumoniae, which is identified in 15-20% of community-acquired pneumonia cases in pregnancy. Recent recommendations by the Infectious Diseases Society of America and the American Thoracic Society on the management of community-acquired pneumonia address diagnostic techniques and management schemes for bacterial and viral pneumonias. These guidelines are discussed in the setting of the pregnant woman with community-acquired pneumonia. (Obstet Gynecol 2009,114:915-22)
引用
收藏
页码:915 / 922
页数:8
相关论文
共 50 条
  • [41] An evaluation of prescribing practices for community-acquired pneumonia (CAP) in Mongolia
    Dorj, Gereltuya
    Hendrie, Delia
    Parsons, Richard
    Sunderland, Bruce
    BMC HEALTH SERVICES RESEARCH, 2013, 13
  • [42] Criteria for clinical stability in hospitalised patients with community-acquired pneumonia
    Aliberti, Stefano
    Zanaboni, Anna Maria
    Wiemken, Tim
    Nahas, Ahmed
    Uppatla, Srinivas
    Morlacchi, Letizia Corinna
    Peyrani, Paula
    Blasi, Francesco
    Ramirez, Julio
    EUROPEAN RESPIRATORY JOURNAL, 2013, 42 (03) : 742 - 749
  • [43] What Is the Best Approach to the Nonresponding Patient with Community-Acquired Pneumonia?
    Sialer, Salvador
    Liapikou, Adamantia
    Torres, Antoni
    INFECTIOUS DISEASE CLINICS OF NORTH AMERICA, 2013, 27 (01) : 189 - +
  • [44] Community-acquired bacterial pneumonia in adults: An update
    Eshwara, Vandana Kalwaje
    Mukhopadhyay, Chiranjay
    Rello, Jordi
    INDIAN JOURNAL OF MEDICAL RESEARCH, 2020, 151 (04) : 287 - 302
  • [45] Antipyretic effect of dexamethasone in community-acquired pneumonia
    Vestjens, Stefan M. T.
    Spoorenberg, Simone M. C.
    Rijkers, Ger T.
    Grutters, Jan C.
    van de Garde, Ewoudt M. W.
    Meijvis, Sabine C. A.
    Bos, Willem Jan W.
    EUROPEAN RESPIRATORY JOURNAL, 2015, 46 (02) : 570 - 573
  • [46] Predictive model for mortality in adults hospitalized for community-acquired pneumonia
    Baez-Saldana, Renata
    Gomez-Zamora, Carlos
    Ferreyra-Reyes, Leticia
    Mongua-Rodriguez, Norma
    Garcia-Garcia, Lourdes
    CIRUGIA Y CIRUJANOS, 2020, 88 (05): : 584 - 590
  • [47] Processes of Care and Outcomes for Community-Acquired Pneumonia
    Lee, Jonathan S.
    Primack, Brian A.
    Mor, Maria K.
    Stone, Roslyn A.
    Obrosky, D. Scott
    Yealy, Donald M.
    Fine, Michael J.
    AMERICAN JOURNAL OF MEDICINE, 2011, 124 (12) : 1175.e9 - 1175.e17
  • [48] Community-acquired pneumonia in the Spanish Emergency departments
    Moya Mir, M. S.
    REVISTA ESPANOLA DE QUIMIOTERAPIA, 2009, 22 (01) : 1 - 3
  • [49] Prognostic value of procalcitonin in community-acquired pneumonia
    Schuetz, P.
    Suter-Widmer, I.
    Chaudri, A.
    Christ-Crain, M.
    Zimmerli, W.
    Mueller, B.
    EUROPEAN RESPIRATORY JOURNAL, 2011, 37 (02) : 384 - 392
  • [50] OVERVIEW OF COMMUNITY-ACQUIRED PNEUMONIA, DIAGNOSIS, AND TREATMENT
    Reazah, Faisal Abdullah Abo
    Al Amoodi, Abdulrahman Ahmad
    Dahhas, Musab Abdullah
    Althebaity, Fares Abed
    Alsheheri, Faisal Dafer
    Al-Sayed, Ali Aziz Mohammed
    Salih, Ahmad Saeed Ali
    Gofashe, Talal Yahya
    Alshaer, Azizah Saeed Abdullah
    AL-Arim, Mohammed Abdullah
    Azzouz, Meaad Mansour
    INDO AMERICAN JOURNAL OF PHARMACEUTICAL SCIENCES, 2019, 6 (01): : 577 - 587